Provided by Tiger Fintech (Singapore) Pte. Ltd.

LISATA THERAPEUTICS INC

2.42
-0.0600-2.42%
Volume:16.36K
Turnover:40.36K
Market Cap:20.35M
PE:-1.01
High:2.51
Open:2.49
Low:2.40
Close:2.48
Loading ...

Lisata Therapeutics Inc - Anticipate Reporting Results From Cendifox Trial in 2025

THOMSON REUTERS
·
10 Dec 2024

Lisata Therapeutics, Kuva Labs Collaborate on Cancer Diagnostics

MT Newswires Live
·
04 Dec 2024

Lisata Therapeutics, Kuva Labs enter license agreement

TIPRANKS
·
03 Dec 2024

Lisata Therapeutics Inc - Kuva Labs to Pay $1 Million Upfront Cash License Fee

THOMSON REUTERS
·
03 Dec 2024

Lisata Therapeutics Inc - Kuva to Assume All Costs for Nanomark Development and Commercialization

THOMSON REUTERS
·
03 Dec 2024

Lisata Therapeutics Inc - Kuva Gains Access to Lisata's Certepetide for Nanomark Platform

THOMSON REUTERS
·
03 Dec 2024

Lisata Therapeutics and Kuva Labs Announce Global License Agreement for Solid Tumor Imaging

THOMSON REUTERS
·
03 Dec 2024

Lisata Therapeutics Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
21 Nov 2024

Q3 2024 Lisata Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
13 Nov 2024

Lisata Therapeutics Inc (LSTA) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Cost ...

GuruFocus.com
·
13 Nov 2024

BRIEF-Lisata Therapeutics And Valo Therapeutics Announce Preclinical Research Collaboration

Reuters
·
06 Nov 2024

Lisata Therapeutics and Valo Therapeutics Announce Preclinical Research Collaboration

THOMSON REUTERS
·
06 Nov 2024

Lisata Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update on Tuesday, November 12, 2024

THOMSON REUTERS
·
06 Nov 2024

Lisata Therapeutics Inc expected to post a loss of 75 cents a share - Earnings Preview

Reuters
·
06 Nov 2024

Lisata Therapeutics, Inc. (LSTA) Upgraded to Buy: Here's What You Should Know

Zacks
·
02 Nov 2024

Lisata Therapeutics to Participate in Upcoming November 2024 Industry and Investor Events

GlobeNewswire
·
31 Oct 2024